Thermo Fisher Scientific
TMO
2,282 hedge funds and large institutions have $186B invested in Thermo Fisher Scientific in 2022 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 824 increasing their positions, 969 reducing their positions, and 122 closing their positions.
23% more funds holding in top 10
Funds holding in top 10: 205 → 253 (+48)
1% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 122
0.66% less ownership
Funds ownership: 88.3% → 87.64% (-0.66%)
1% less call options, than puts
Call options by funds: $1.07B | Put options by funds: $1.08B
1% less funds holding
Funds holding: 2,315 → 2,282 (-33)
8% less capital invested
Capital invested by funds: $203B → $186B (-$17.1B)
15% less repeat investments, than reductions
Existing positions increased: 824 | Existing positions reduced: 969
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$896M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$695M |
| 3 |
Goldman Sachs
New York
|
+$305M |
| 4 |
Jennison Associates
New York
|
+$289M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$247M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$982M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$265M |
| 3 |
AWA
Aaron Wealth Advisors
Chicago,
Illinois
|
-$265M |
| 4 |
BMSSC
B. Metzler seel. Sohn & Co
Frankfurt,
Germany
|
-$239M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$239M |
TMO Hedge Fund Activity: Q2 2022 in Review
2,282 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2022, worth a combined $186B — down 8.5% from $203B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new TMO positions and 122 closed out — a net gain of 1 holder — while 824 added to existing stakes and 969 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $896M. The largest seller was T. Rowe Price Associates, cutting an estimated $982M.
- 2,282 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2022, down from 2,315 in Q1 2022.
- Funds reported $186B of Thermo Fisher Scientific stock for Q2 2022, down 8.5% quarter-over-quarter.
- 123 funds opened new Thermo Fisher Scientific positions in Q2 2022 and 122 closed out, a net change of +1 holder.
- The largest Thermo Fisher Scientific buyer in Q2 2022 was Morgan Stanley, an estimated $896M added.
- The largest Thermo Fisher Scientific seller in Q2 2022 was T. Rowe Price Associates, an estimated $982M sold.
Based on aggregated 13F filings for Q2 2022.